DBV Technologies (DBVT) Current Assets (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Current Assets of $201.9 million for Q2 2026, up 66.53% year-on-year from $121.2 million in Q2 2025, and down 18.16% on a QoQ basis from $246.7 million in Q1 2026.

DBV Technologies (DBVT) Current Assets (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Current Assets for 12 consecutive years, with $201.9 million the latest figure, recorded in Q2 2026.

  • Quarterly Current Assets rose 66.53% year-over-year to $201.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $201.9 million (up 66.53% YoY) and the FY2025 annual result came in at $212.9 million, up 379.63% from the prior year.
  • Current Assets retreated to $201.9 million in Q2 2026 per DBVT's latest filing, from $246.7 million in the prior quarter.
  • Over the last five years, Current Assets for DBVT reached as high as $260.0 million in Q2 2022 and fell as low as $29.1 million in Q1 2025.
  • A 5-year average of $153.1 million and a median of $164.1 million in 2023 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2025 — Current Assets slumped 75.62% — and 2026, when it surged 746.37%.
  • Year by year, Current Assets stood at $223.1 million in 2022, then slipped by 28.76% to $158.9 million in 2023, then tumbled by 72.07% to $44.4 million in 2024, then surged by 379.63% to $212.9 million in 2025, then dropped by 5.17% to $201.9 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $201.9 million, $246.7 million, and $212.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 289.93 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 73.04 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 6.60 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 521.86 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 8.07 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.97 Bn
10 DBV Technologies 267.50 Mn 92.60 Mn - 201.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 201.90 Mn
Mar 31, 2026 246.70 Mn
Dec 31, 2025 212.90 Mn
Sep 30, 2025 88.88 Mn
Jun 30, 2025 121.24 Mn
Mar 31, 2025 29.15 Mn
Dec 31, 2024 44.39 Mn
Sep 30, 2024 68.76 Mn
Jun 30, 2024 89.96 Mn
Mar 31, 2024 119.56 Mn
Dec 31, 2023 158.92 Mn
Sep 30, 2023 169.27 Mn
Jun 30, 2023 195.54 Mn
Mar 31, 2023 210.24 Mn
Dec 31, 2022 223.07 Mn
Sep 30, 2022 225.70 Mn
Jun 30, 2022 259.95 Mn
Mar 31, 2022 90.44 Mn
Dec 31, 2021 114.39 Mn
Sep 30, 2021 110.14 Mn